Several drugs containing the ingredient valsartan are being recalled by their manufacturers. An impurity, N-nitrosodimethylamine (NDMA), was found in the valsartan used in these products. NDMA is a potential human carcinogen, which means that it could cause cancer with long-term exposure. Learn more by visiting the Health Canada advisory.
Home News Several Drugs Containing Valsartan Being Recalled Due to Contamination With a Potential Carcinogen
Related News from the College
Information Session: PACE for Pharmacy Technician Ap...
POSTED
Apr 16th, 2024 -
1 min read
Pharmacy technicians and pharmacists are invited to attend one of two virtual information sessions on the upcoming Practice Assessment of...
Time-delayed safes for securing narcotics now fully ...
POSTED
Apr 10th, 2024 -
3 min read
Sending a strong signal to criminals, time-delayed safes are a proven way to deter crime and reduce pharmacy...
Community Pharmacy Accreditation Renewal Now Open – ...
POSTED
Apr 2nd, 2024 -
2 min read
The College’s online annual accreditation renewal for community pharmacies is now available. Email reminders will be sent to...